Author

Maria T. Abreu 1

1 University of Miami Miller School,Miami,United States

ABSENCE OF BOWEL URGENCY IS ASSOCIATED WITH SIGNIFICANTLY IMPROVED INFLAMMATORY BOWEL DISEASE RELATED QUALITY OF LIFE IN A PHASE 2 TRIAL OF MIRIKIZUMAB IN PATIENTS WITH ULCERATIVE COLITIS

Marla C. Dubinsky, Scott D. Lee, Remo Panaccione, Maria T. Abreu, Severine Vermeire, Trevor Lissoos, Nathan Morris, Vipin Arora, Mingyang Shan, April Naegeli, Bruce E. Sands

Best of IBD

Maria T. Abreu

Closing the gap: Negotiating for physicians and scientists

Maria T. Abreu

Diagnostic strategy to make a confident diagnosis of IBD

Maria T. Abreu

Early Improvement After Intravenous Ustekinumab Induction in Patients with Ulcerative Colitis: Results from the UNIFI Induction Trial

Bruce E. Sands, Maria T. Abreu, C Marano, Thomas Baker, Christopher D. O'Brien, Hongyan Zhang, Jewel Johanns, David Rowbotham, Rupert W Leong, Silvio Danese

EFFECT OF USTEKINUMAB MAINTENANCE THERAPY ON STOOL FREQUENCY AND RECTAL BLEEDING THROUGH 2 YEARS IN THE UNIFI PHASE 3 STUDY IN ULCERATIVE COLITIS

Laurent Peyrin-Biroulet, Maria T. Abreu, Silvio Danese, Colleen W. Marano, Yiying Zhou, Hongyan Zhang, Rupert W Leong, David Rowbotham, Remo Panaccione, William Sandborn

EFFICACY AND SAFETY OF MIRIKIZUMAB AFTER 52-WEEKS MAINTENANCE TREATMENT IN PATIENTS WITH MODERATE-TO-SEVERE CROHN'S DISEASE

Bruce E. Sands, William Sandborn, Laurent Peyrin-Biroulet, Peter Higgins, Fumihito Hirai, Vipul Jairath, Geert R. D'Haens, Maria T. Abreu, Ruth Belin, Elisa Gomez Valderas, Debra Miller, April Naegeli, Vipin Arora, Paul Pollack, Jay Tuttle, Toshifumi Hibi

Efficacy and Safety of Ustekinumab for Ulcerative Colitis Through 2 Years: UNIFI Long-term Extension

Bruce E. Sands, William Sandborn, Remo Panaccione, Christopher D. O'Brien, Hongyan Zhang, Jewel Johanns, Yiying Zhou, Ilia Tikhonov, Laurent Peyrin-Biroulet, Gert Van Assche, Silvio Danese, Stephan Targan, Maria T. Abreu, Tadakazu Hisamatsu, Ellen Scherl, Rupert W Leong, David Rowbotham, Ramesh P. Arasaradnam, Colleen W.

EFFICACY OF USTEKINUMAB FOR ULCERATIVE COLITIS IN PATIENTS THROUGH 3 YEARS: UNIFI LONG-TERM EXTENSION

David Rowbotham, Maria T. Abreu, Silvio Danese, William J. Sandborn, Ye Miao, Hongyan Zhang, Remo Panaccione, Tadakazu Hisamatsu, Ellen Scherl, Rupert W Leong, Ramesh P. Arasaradnam, Waqqas Afif, Laurent Peyrin-Biroulet, Bruce E. Sands, Colleen W. Marano

Impact of Response and Inflammatory Burden at Start of Maintenance Therapy on Clinical Efficacy of Ustekinumab Dosing Regimen in UC: Week 44 Results from UNIFI

Remo Panaccione, Laurent Peyrin-Biroulet, Silvio Danese, Colleen W. Marano, Christopher D. O'Brien, Philippe Szapary, Hongyan Zhang, Jewel Johanns, Rupert W Leong, Ramesh P. Arasaradnam, David Rowbotham, Maria T. Abreu, Bruce E. Sands

Item 1 - 10 / 23
1
2 3